TARA Protara Therapeutics, Inc. - Common Stock
$4,08
Prezzo · Ago 19, 2026
Fondamentali al Ago 11, 2026
Intervallo 52 sett.
$3–$8
23% of range
Rating Analisti
BUY
14 analysts
Prezzo Obiettivo
$27
+552% upside
P/E (TTM)
-3.0
ROE
-33.7%
Margine di Profitto Netto
—
Informazioni su Protara Therapeutics, Inc. - Common Stock Panoramica della società da Wikipedia
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
Leggi di più
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
Company History
Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include MPM Capital, Rockhill Partners, TVM Capital, Skyline Ventures, Prism VentureWorks, Vectis Life Sciences and Intersouth Partners. They have invested over $72 million in the company.
The company is led by Timothy Noyes, CEO; Steven Burke, CMO; George Eldridge, CFO; and Scott Toner, director of marketing.
On March 5, 2009, the company announced that it had raised $32 million from its existing investors plus MPM Capital and Vectis Life Sciences. Proteon also announced that it had entered into an option agreement to be acquired by Novartis for up to $550 million. The company went public in 2014.
In September 2019, Proteon Therapeutics merged with ArTara Therapeutics.
PRT-201
Proteon is developing PRT-201 (vonapanitase), a drug to improve blood flow following vascular surgery procedures, and, more broadly, is interested in vascular access for hemodialysis and peripheral arterial disease (PAD). PRT-201 is a recombinant human elastase manufactured for Proteon by Lonza.
In September 2008, the company announced that the Food and Drug Administration had granted fast track status to PRT-201.
In December 2016, they announced that the phase III trial of PRT-201 hadn't reached its primary endpoint, causing Proteon's stock price to drop more than 75%.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
TARA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$4.08
Capitalizzazione di Mercato
$218M
P/E (TTM)
-3.0
EPS (TTM)
$-1.34
Ricavi (TTM)
—
Rendimento div.
—
ROE
-33.7%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$3 – $8
TARA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
—
EPS
$-1.34
2021-12-31
→
2025-12-31
Flusso di cassa libero
$-56M
2016-12-31
→
2025-12-31
Margini
—
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
TARA
Mediana dei peer
P/E (TTM)
-3.0
88.5
P/B
1.1
3.6
Price / FCF (Prezzo / FCF)
-3.9
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
TARA
Mediana dei peer
ROA
-29.4%
-38.8%
ROE
-33.7%
-61.0%
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
TARA
Mediana dei peer
Current Ratio (Rapporto corrente)
14.6
3.9
Quick Ratio
14.2
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
TARA
Mediana dei peer
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
TARA
Mediana dei peer
TARA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
14 analisti
- Acquisto forte 3 21,4%
- Compra 10 71,4%
- Mantieni 1 7,1%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
7 analisti · 2026-08-13
Mediana
$26.00
Media
$26.57
← Sotto tutti i target
$4.08
Basso
$24.00
Alto
$30.00
Target mediano
$26.00
+538,0%
Target medio
$26.57
+552,1%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.07%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $-0.31 | $-0.38 | 0.07% |
| 31 Dicembre 2025 | $-0.37 | $-0.33 | -0.04% |
| 30 Settembre 2025 | $-0.31 | $-0.39 | 0.08% |
| 30 Giugno 2025 | $-0.35 | $-0.41 | 0.06% |
| 31 Marzo 2025 | $-0.29 | $-0.46 | 0.17% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| CNXU | — | — | — | — | — | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| R&D Expense | $43M | $32M | $25M | $17M | $21M | $12M | $4M | $12M | $22M | $19M | $12M | $6M | |
| SG&A Expense | $22M | $17M | $19M | $21M | $26M | $22M | $4M | $10M | $9M | $10M | $8M | $4M | |
| Operating Expenses | $65M | $49M | $44M | $67M | $47M | $34M | $8M | $21M | $30M | $29M | $21M | $11M | |
| Operating Income | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-8M | |
| Interest Expense | · | · | · | · | $0 | $34.0K | · | · | · | · | · | $857.0K | |
| Interest Income | $6M | $4M | $3M | $1M | $237.0K | $500.0K | · | · | · | · | · | · | |
| Other Non-op | $7M | $5M | $3M | $1M | $237.0K | $466.0K | · | $207.0K | $139.0K | $-14.0K | $-651.0K | $5M | |
| Pretax Income | $57M | $45M | · | · | · | · | $-15M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $-110.0K | |
| Net Income | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| EPS (Basic) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| Shares (Basic) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | 11,232,576 | · | · | · | · | · | · | · | |
| EBITDA | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-15M | · | · | $-29M | $-21M | $-8M |
Stato Patrimoniale 23
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $163M | $40M | $24M | $36M | $169M | $564.0K | $19M | $21M | $36M | $40M | $69M | |
| Short-term Investments | $106M | $7M | $26M | $60M | $56M | · | · | $2M | $21M | $5M | $25M | $15M | |
| Prepaid Expense | $4M | $2M | $3M | $2M | $2M | $787.0K | $78.0K | $1M | $1M | $1M | $1M | $1M | |
| Other Current Assets | $65.0K | $2.0K | $37.0K | $127.0K | $34.0K | $52.0K | · | · | · | · | · | · | |
| Current Assets | $160M | $172M | $69M | $86M | $93M | $169M | $764.0K | $23M | $43M | $43M | $67M | $85M | |
| PP&E (Net) | $759.0K | $1M | $1M | $2M | $2M | $1M | $459.0K | $263.0K | $259.0K | $372.0K | $224.0K | $83.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $1M | $475.0K | $1M | $971.0K | $937.0K | $665.0K | $467.0K | |
| Accum. Depreciation | $1M | $1M | $824.0K | $483.0K | $236.0K | $119.0K | $16.0K | $827.0K | $712.0K | $565.0K | $441.0K | $384.0K | |
| Goodwill | · | · | · | · | $30M | $30M | · | · | · | · | · | · | |
| Other Non-current Assets | $20.0K | $27.0K | $11.0K | $16.0K | $865.0K | $1M | · | · | $218.0K | $393.0K | $706.0K | $114.0K | |
| Total Assets | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Accounts Payable | $3M | $4M | $2M | $2M | $954.0K | $914.0K | $716.0K | $441.0K | $291.0K | $556.0K | $1M | $917.0K | |
| Accrued Liabilities | $6M | $5M | $3M | $3M | $2M | $2M | $3M | $3M | $9M | $5M | $3M | $1M | |
| Current Liabilities | $11M | $11M | $6M | $6M | $4M | $3M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Capital Leases | $2M | $3M | $4M | $5M | $6M | $999.0K | · | · | · | · | · | · | |
| Total Liabilities | $13M | $14M | $11M | $11M | $11M | $4M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Common Stock | $54.0K | $35.0K | $11.0K | $11.0K | $11.0K | $11.0K | $3.0K | · | $18.0K | $17.0K | $16.0K | $16.0K | |
| Paid-in Capital | $499M | $412M | $269M | $263M | $256M | $246M | $11M | $209M | $203M | $198M | $195M | $192M | |
| Retained Earnings | $-302M | $-245M | $-200M | $-160M | $-94M | $-47M | $-13M | $-210M | $-190M | $-160M | $-131M | $-110M | |
| AOCI | $90.0K | $2.0K | $-31.0K | $-688.0K | $-211.0K | · | $3.0K | $5.0K | $-14.0K | · | $-11.0K | $-6.0K | |
| Stockholders' Equity | $196M | $167M | $68M | $102M | $162M | $199M | $-2M | $5M | $35M | $38M | $63M | $82M | |
| Liabilities + Equity | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Shares Outstanding | 53,587,260 | 35,044,772 | 11,364,903 | 11,267,389 | 11,235,731 | 11,211,840 | 2,627,533 | 481,091 | 17,674,729 | 16,603,559 | 16,501,500 | 16,448,455 |
Flusso di cassa 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $123.0K | $57.0K | $30.0K | |
| Stock-based Comp | $4M | $4M | $6M | $7M | $10M | $10M | $424.0K | $3M | $3M | $3M | $2M | $459.0K | |
| Deferred Tax | $-11M | $-20M | $-14M | $-9M | $-5M | $-9M | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $1M | $2M | $-7M | |
| Operating Cash Flow | $-56M | $-36M | $-38M | $-26M | $-35M | $-23M | $-5M | $-23M | $-22M | $-24M | $-18M | $-10M | |
| CapEx | $94.0K | $63.0K | $45.0K | $120.0K | $596.0K | $884.0K | $475.0K | $119.0K | $35.0K | $271.0K | $198.0K | $51.0K | |
| Investing Cash Flow | $-139M | $19M | $53M | $15M | $-98M | $3M | $-475.0K | $18M | $-16M | $20M | $-11M | · | |
| Stock Issued | · | · | · | · | · | $74M | · | · | · | · | · | $62M | |
| Stock Repurchased | · | · | $91.0K | $90.0K | $228.0K | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $-91.0K | $-90.0K | $-228.0K | $66M | · | · | · | · | · | $62M | |
| Financing Cash Flow | $83M | $140M | $-91.0K | $-90.0K | $-228.0K | $189M | $500.0K | $3M | $23M | $208.0K | $163.0K | · | |
| Net Change in Cash | · | · | · | · | · | · | $-13M | $-2M | $-15M | $-4M | $-29M | $66M | |
| Free Cash Flow | $-56M | $-36M | $-38M | $-27M | $-35M | $-24M | $-16M | · | · | $-24M | $-18M | $-10M |
Redditività 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -257.1% | |
| Net Margin | · | · | · | · | · | -7291.4% | · | · | · | · | · | -113.4% | |
| EBITDA Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -256.1% | |
| ROA | -29.4% | -34.2% | -42.0% | -46.1% | -25.1% | -33.2% | -98.3% | · | · | -51.4% | -28.1% | -7.4% | |
| ROE | -33.7% | -35.8% | -55.6% | -54.7% | -28.4% | -17.2% | -449.1% | · | · | -56.0% | -29.3% | 37.0% |
Liquidità e Solvibilità 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 | 58.1 | 12.0 | · | · | 8.4 | 16.1 | 36.2 | |
| Quick Ratio | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 | 57.8 | 10.6 | · | · | 8.1 | 15.8 | 35.8 | |
| Interest Coverage | · | · | · | · | · | -1013.1 | · | · | · | · | · | -8.8 |
Efficienza 1
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | 0.1 |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Net Income TTM | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Market Cap | $286M | $185M | $21M | $30M | $76M | $271M | $9M | · | · | $1.26B | $10.24B | $6.84B | |
| P/E | -4.0 | -2.4 | -0.5 | -0.5 | -1.6 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | 2321.1 | |
| P/B | 1.5 | 1.1 | 0.3 | 0.3 | 0.5 | 1.4 | 1.4 | · | · | 32.8 | 161.5 | 83.0 | |
| P / Tangible Book | 1.5 | 1.1 | 0.3 | 0.3 | 0.6 | 1.6 | · | · | · | · | · | · | |
| P / Cash Flow | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.6 | -0.6 | · | · | -53.3 | -582.8 | -684.9 | |
| P / FCF | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.2 | -0.6 | · | · | -52.7 | -576.3 | -681.5 | |
| Earnings Yield | -25.1% | -41.1% | -190.4% | -218.7% | -62.4% | · | · | · | · | · | · | · |
Conto Economico 12
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $17M | $14M | $13M | $10M | $11M | $9M | $9M | $8M | $6M | $8M | $6M | $6M | $7M | $5M | $5M | $3M | |
| SG&A Expense | $6M | $6M | $6M | $5M | $6M | $5M | $5M | $4M | $4M | $4M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Operating Expenses | $23M | $20M | $19M | $15M | $17M | $14M | $14M | $12M | $11M | $12M | $11M | $11M | $12M | $10M | $40M | $8M | |
| Operating Income | $-23M | $-20M | $-19M | $-15M | $-17M | $-14M | $-14M | $-12M | $-11M | $-12M | $-11M | $-11M | $-12M | $-10M | $-40M | $-8M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Net Income | $-22M | $-18M | $-17M | $-13M | $-15M | $-12M | $-13M | $-11M | $-10M | $-11M | $-10M | $-10M | $-11M | $-9M | $-39M | $-8M | |
| EPS (Basic) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| EPS (Diluted) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| Shares (Basic) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| Shares (Diluted) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| EBITDA | $-23M | $-20M | · | $-15M | $-17M | $-14M | · | $-12M | $-11M | $-12M | · | $-11M | $-12M | $-10M | · | $-8M |
Stato Patrimoniale 23
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $15M | $50M | $13M | $31M | $91M | $163M | $52M | $90M | $52M | $40M | $34M | $34M | $21M | $24M | $47M | |
| Short-term Investments | $125M | $121M | $106M | $120M | $91M | $33M | $7M | $30M | · | $3M | $26M | $40M | $46M | $66M | $60M | $49M | |
| Prepaid Expense | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $4M | $3M | $3M | $3M | $4M | $4M | $8M | $2M | $2M | |
| Other Current Assets | $230.0K | $17.0K | $65.0K | $218.0K | $78.0K | $16.0K | $2.0K | $3.0K | $4.0K | $3.0K | $37.0K | $2.0K | $1.0K | $127.0K | $127.0K | · | |
| Current Assets | $146M | $140M | $160M | $136M | $125M | $127M | $172M | $85M | $92M | $58M | $69M | $78M | $84M | $95M | $86M | $99M | |
| PP&E (Net) | $1M | $669.0K | $759.0K | $828.0K | $912.0K | $988.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $824.0K | · | · | · | $483.0K | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Assets | $74.0K | $76.0K | $20.0K | $21.0K | $29.0K | $35.0K | $27.0K | $33.0K | $19.0K | $31.0K | $11.0K | $3M | $3M | $586.0K | $16.0K | $734.0K | |
| Total Assets | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Accounts Payable | $5M | $4M | $3M | $5M | $5M | $2M | $4M | $2M | $1M | $972.0K | $2M | $3M | $2M | $4M | $2M | $456.0K | |
| Accrued Liabilities | $7M | $4M | $6M | $4M | $3M | $4M | $5M | $5M | $3M | $4M | $3M | $3M | $2M | $1M | $3M | $2M | |
| Current Liabilities | $13M | $9M | $11M | $10M | $10M | $7M | $11M | $9M | $6M | $6M | $6M | $7M | $5M | $6M | $6M | $4M | |
| Capital Leases | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | |
| Total Liabilities | $15M | $11M | $13M | $12M | $13M | $10M | $14M | $12M | $10M | $10M | $11M | $12M | $10M | $12M | $11M | $9M | |
| Common Stock | $59.0K | $55.0K | $54.0K | $39.0K | $39.0K | $39.0K | $35.0K | $21.0K | $21.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | |
| Paid-in Capital | $503M | $502M | $499M | $417M | $416M | $415M | $412M | $314M | $313M | $270M | $269M | $267M | $266M | $264M | $263M | $261M | |
| Retained Earnings | $-342M | $-320M | $-302M | $-285M | $-272M | $-257M | $-245M | $-232M | $-221M | $-211M | $-200M | $-190M | $-180M | $-169M | $-160M | $-121M | |
| AOCI | $-363.0K | $-364.0K | $90.0K | $143.0K | $77.0K | $89.0K | $2.0K | $29.0K | · | $-1.0K | $-31.0K | $-165.0K | $-336.0K | $-469.0K | $-688.0K | $-1M | |
| Stockholders' Equity | $161M | $181M | $196M | $132M | $144M | $158M | $167M | $82M | $92M | $58M | $68M | $77M | $85M | $95M | $102M | $139M | |
| Liabilities + Equity | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Shares Outstanding | 59,083,935 | 55,055,582 | 53,587,260 | 38,587,260 | 38,581,863 | 38,577,813 | 35,044,772 | 20,629,772 | 11,364,903 | 11,433,837 | 11,364,903 | 11,364,903 | 11,307,962 | 11,306,753 | 11,267,389 | 11,267,389 |
Flusso di cassa 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $903.0K | $833.0K | $904.0K | $931.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | |
| Operating Cash Flow | $-15M | $-21M | $-17M | $-12M | $-12M | $-15M | $-9M | $-8M | $-8M | $-10M | $-9M | $-7M | $-9M | $-13M | $-5M | $-5M | |
| CapEx | · | · | $24.0K | $4.0K | $22.0K | $44.0K | $0 | $8.0K | · | · | $0 | $37.0K | $2.0K | $6.0K | $6.0K | $83.0K | |
| Investing Cash Flow | $18M | $-15M | $-27M | $-7M | $-48M | $-58M | $22M | $-29M | $3M | $23M | $15M | $6M | $22M | $10M | $-18M | $19M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $76.0K | · | $27.0K | $0 | $64.0K | $0 | $18.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $-76.0K | · | · | · | $-64.0K | · | · | |
| Financing Cash Flow | $-26.0K | $1M | $81M | $13.0K | $8.0K | $2M | $98M | $0 | $42M | $-76.0K | $0 | $-27.0K | $0 | $-64.0K | $0 | $-18.0K | |
| Free Cash Flow | · | · | · | · | · | $-15M | · | · | · | · | · | · | · | $-13M | · | · |
Redditività 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -1464.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -13.0% | -9.9% | · | -11.1% | -11.6% | -10.1% | · | -12.3% | -9.7% | -12.7% | · | -8.3% | -9.0% | -6.8% | · | -4.7% | |
| ROE | -14.2% | -10.5% | · | -12.4% | -12.7% | -11.0% | · | -14.1% | -10.7% | -14.5% | · | -9.1% | -9.8% | -7.3% | · | -5.0% |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.0 | 15.7 | · | 13.7 | 12.8 | 18.0 | · | 9.8 | 16.3 | 10.5 | · | 11.5 | 17.1 | 14.8 | · | 26.6 | |
| Quick Ratio | 10.7 | 15.2 | · | 13.4 | 12.5 | 17.7 | · | 9.4 | 15.9 | 10.0 | · | 10.9 | 16.3 | 13.5 | · | 26.0 |
Efficienza 1
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-68M | $-58M | · | $-51M | $-48M | $-44M | · | $-42M | $-42M | $-41M | · | $-38M | $-37M | $-36M | · | $-38M | |
| Market Cap | $226M | $287M | · | $168M | $117M | $164M | · | $38M | $24M | $46M | · | $19M | $27M | $35M | · | $33M | |
| P/E | -2.9 | -4.1 | · | -3.0 | -1.9 | -1.9 | · | -0.7 | -0.6 | -1.1 | · | -0.5 | -0.7 | -1.0 | · | -0.9 | |
| P/B | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.2 | |
| P / Tangible Book | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -11.2 | · | · | · | -4.4 | · | · | · | -2.7 | · | · | |
| P / FCF | · | · | · | · | · | -11.1 | · | · | · | · | · | · | · | -2.7 | · | · | |
| Earnings Yield | -34.8% | -24.2% | · | -33.3% | -52.5% | -51.9% | · | -152.5% | -158.2% | -90.8% | · | -200.6% | -135.6% | -102.2% | · | -113.5% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utile netto | $-57M | $-45M | $-40M | $-66M | $-47M |
| EPS Diluito | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 |
| Quick Ratio | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-56M | $-36M | $-38M | $-27M | $-35M |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 127 filer · $162.3M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 31 (+4 vs trimestre precedente) | 16 (-5 vs trimestre precedente) | 39 (-8 vs trimestre precedente) | 33 (+10 vs trimestre precedente) | +760K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $27.154.562 | 5.207.011 | 16,73% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $11.846.454 | 3.101.166 | 7,30% | Azioni |
| Velan Capital Investment Management LP | $10.866.571 | 2.844.652 | 6,70% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.786.508 | 2.300.133 | 5,41% | Azioni |
| Blackstone Inc. | $8.654.263 | 2.265.514 | 5,33% | Azioni |
| ORBIMED ADVISORS LLC | $8.480.400 | 2.220.000 | 5,23% | Azioni |
| Sio Capital Management, LLC | $7.341.551 | 1.921.872 | 4,52% | Azioni |
| ACORN CAPITAL ADVISORS, LLC | $6.693.079 | 1.752.115 | 4,12% | Azioni |
| Integral Health Asset Management, LLC | $5.730.000 | 1.500.000 | 3,53% | Azioni |
| 5AM Venture Management, LLC | $5.232.567 | 1.369.782 | 3,22% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $4.362.540 | 1.141.710 | 2,69% | Azioni |
| STATE STREET CORP | $4.080.887 | 1.068.295 | 2,51% | Azioni |
| Qube Research & Technologies Ltd | $3.993.871 | 1.045.516 | 2,46% | Azioni |
| Balyasny Asset Management L.P. | $3.921.960 | 1.026.691 | 2,42% | Azioni |
| BAKER BROS. ADVISORS LP | $3.711.565 | 971.614 | 2,29% | Azioni |
| ADAR1 Capital Management, LLC | $3.592.756 | 940.512 | 2,21% | Azioni |
| CITADEL ADVISORS LLC | $3.414.045 | 893.729 | 2,10% | Azioni |
| BANK OF AMERICA CORP /DE/ | $3.287.679 | 860.649 | 2,03% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $2.389.918 | 625.633 | 1,47% | Azioni |
| Point72 Asset Management, L.P. | $2.096.920 | 548.932 | 1,29% | Azioni |
| Catalio Capital Management, LP | $1.986.965 | 520.148 | 1,22% | Azioni |
| GOLDMAN SACHS GROUP INC | $1.936.106 | 506.834 | 1,19% | Azioni |
| Walleye Capital LLC | $1.930.750 | 505.432 | 1,19% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.878.130 | 491.657 | 1,16% | Azioni |
| MORGAN STANLEY | $1.833.917 | 480.083 | 1,13% | Azioni |
| UBS Group AG | $1.723.538 | 451.188 | 1,06% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $1.278.489 | 334.683 | 0,79% | Azioni |
| Verdad Advisers, LP | $1.192.791 | 312.249 | 0,73% | Azioni |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1.129.058 | 295.565 | 0,70% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $960.730 | 251.500 | 0,59% | Azioni |
| OPPENHEIMER & CO INC | $910.543 | 238.362 | 0,56% | Azioni |
| Jump Financial, LLC | $775.842 | 203.100 | 0,48% | Azioni |
| CIBC WORLD MARKET INC. | $636.011 | 166.495 | 0,39% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $603.449 | 157.971 | 0,37% | Azioni |
| J. Goldman & Co LP | $515.700 | 135.000 | 0,32% | Azioni |
| SUPERSTRING CAPITAL MANAGEMENT LP | $463.966 | 121.457 | 0,29% | Azioni |
| Fisher Asset Management, LLC | $380.342 | 99.566 | 0,23% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $376.220 | 98.487 | 0,23% | Azioni |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $325.961 | 85.330 | 0,20% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $266.071 | 69.652 | 0,16% | Azioni |
| FMR LLC | $260.012 | 68.066 | 0,16% | Azioni |
| XTX Topco Ltd | $244.281 | 63.948 | 0,15% | Azioni |
| RHUMBLINE ADVISERS | $241.589 | 63.245 | 0,15% | Azioni |
| TRUIST FINANCIAL CORP | $229.200 | 60.000 | 0,14% | Azioni |
| Assenagon Asset Management S.A. | $229.024 | 59.954 | 0,14% | Azioni |
| Trexquant Investment LP | $227.733 | 59.616 | 0,14% | Azioni |
| DEUTSCHE BANK AG\ | $220.464 | 57.713 | 0,14% | Azioni |
| ALPS ADVISORS INC | $217.897 | 57.041 | 0,13% | Azioni |
| AMERIPRISE FINANCIAL INC | $214.863 | 56.247 | 0,13% | Azioni |
| PRUDENTIAL FINANCIAL INC | $193.789 | 50.730 | 0,12% | Azioni |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $191.000 | 50.000 | 0,12% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $154.252 | 40.380 | 0,10% | Azioni |
| Alyeska Investment Group, L.P. | $151.753 | 39.726 | 0,09% | Azioni |
| Quadrature Capital Ltd | $150.199 | 39.319 | 0,09% | Azioni |
| Marex Group Ltd | $134.655 | 35.250 | 0,08% | Azioni |
| WINTON GROUP Ltd | $125.296 | 32.800 | 0,08% | Azioni |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $113.454 | 29.700 | 0,07% | Azioni |
| MetLife Investment Management, LLC | $108.404 | 28.378 | 0,07% | Azioni |
| MARSHALL WACE, LLP | $106.995 | 28.009 | 0,07% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $93.988 | 18.040 | 0,06% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $92.043 | 24.095 | 0,06% | Azioni |
| WOLVERINE TRADING, LLC | $88.200 | 20.000 | 0,05% | Opzione Put |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $87.478 | 22.900 | 0,05% | Opzione Put |
| CITIGROUP INC | $80.698 | 21.125 | 0,05% | Azioni |
| Jain Global LLC | $80.220 | 21.000 | 0,05% | Azioni |
| Invesco Ltd. | $78.295 | 20.496 | 0,05% | Azioni |
| Vanguard Global Advisers, LLC | $76.885 | 20.127 | 0,05% | Azioni |
| PRELUDE CAPITAL MANAGEMENT, LLC | $74.922 | 19.613 | 0,05% | Azioni |
| EntryPoint Capital, LLC | $73.673 | 19.286 | 0,05% | Azioni |
| LPL Financial LLC | $73.077 | 19.130 | 0,05% | Azioni |
| VANGUARD GROUP INC | $70.479 | 13.223 | 0,04% | Azioni |
| Squarepoint Ops LLC | $69.234 | 18.124 | 0,04% | Azioni |
| IEQ CAPITAL, LLC | $68.489 | 17.929 | 0,04% | Azioni |
| Police & Firemen's Retirement System of New Jersey | $67.114 | 17.569 | 0,04% | Azioni |
| BARCLAYS PLC | $60.665 | 15.881 | 0,04% | Azioni |
| BlackRock, Inc. | $58.950 | 15.432 | 0,04% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $56.834 | 14.878 | 0,04% | Azioni |
| INTECH INVESTMENT MANAGEMENT LLC | $51.807 | 13.562 | 0,03% | Azioni |
| WOLVERINE TRADING, LLC | $51.315 | 11.636 | 0,03% | Azioni |
| Mariner, LLC | $45.441 | 11.899 | 0,03% | Azioni |
| Bank of New York Mellon Corp | $43.877 | 11.486 | 0,03% | Azioni |
| VOYA INVESTMENT MANAGEMENT LLC | $43.812 | 11.469 | 0,03% | Azioni |
| D. E. Shaw & Co., Inc. | $42.452 | 11.113 | 0,03% | Azioni |
| COMMONWEALTH EQUITY SERVICES, LLC | $42.020 | 11.000 | 0,03% | Azioni |
| WELLS FARGO & COMPANY/MN | $41.161 | 10.775 | 0,03% | Azioni |
| Essential Partners LLC | $37.444 | 9.802 | 0,02% | Azioni |
| MERCER GLOBAL ADVISORS INC /ADV | $34.525 | 9.038 | 0,02% | Azioni |
| NORTHERN TRUST CORP | $32.061 | 8.393 | 0,02% | Azioni |
| CWM, LLC | $30.458 | 5.846 | 0,02% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $30.178 | 7.900 | 0,02% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $28.788 | 7.536 | 0,02% | Azioni |
| Tower Research Capital LLC (TRC) | $19.062 | 4.990 | 0,01% | Azioni |
| Legal & General Group Plc | $17.129 | 4.490 | 0,01% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14.645 | 2.811 | 0,01% | Azioni |
| Ameritas Investment Partners, Inc. | $12.598 | 3.298 | 0,01% | Azioni |
| Nuveen, LLC | $9.642 | 2.524 | 0,01% | Azioni |
| Integrated Wealth Concepts LLC | $6.684 | 1.750 | 0,00% | Azioni |
| Arax Advisory Partners | $6.383 | 1.671 | 0,00% | Azioni |
| Russell Investments Group, Ltd. | $6.085 | 1.593 | 0,00% | Azioni |
| ROYAL BANK OF CANADA | $6.000 | 1.577 | 0,00% | Azioni |
Insider aziendali 40 insider · 16 dirigenti · 20 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jesse Shefferman | CEO and President | 29 Giugno 2026 M | 691.832 | 0 | 1 | $-882.160 |
| Timothy P Noyes | President and CEO | 31 Gennaio 2019 A | 0 | 0 | 0 | $0 |
| Patrick Fabbio | Chief Financial Officer | 26 Gennaio 2026 F | 64.115 | 0 | 0 | $0 |
| Blaine Davis | Chief Financial Officer | 15 Luglio 2022 F | 20.662 | 0 | 0 | $0 |
| George Arthur Eldridge, | Sr VP, CFO, Treasr, Asst Secy | 18 Gennaio 2019 A | 29.132 | 0 | 0 | $0 |
| William Conkling | Chief Commercial Officer | 02 Giugno 2026 F | 69.992 | 0 | 0 | $0 |
| Jacqueline Zummo | Chief R&D Officer | 08 Aprile 2026 S | 94.827 | 0 | 2 | $-124.989 |
| Hannah Fry | VP, Controller | 26 Gennaio 2026 F | 42.723 | 0 | 0 | $0 |
| Leonardo Viana Nicacio | Chief Medical Officer | 16 Gennaio 2026 A | 78.181 | 0 | 0 | $0 |
| Jathin Bandari | Chief Medical Officer | 19 Gennaio 2024 A | 56.704 | 0 | 0 | $0 |
| Julio Casoy | Chief Medical Officer | 09 Gennaio 2020 A | 45.500 | 0 | 0 | $0 |
| Steven Keith Burke | SVP and Chief Medical Officer | 15 Marzo 2019 G | 26.332 | 0 | 0 | $0 |
| Bradley J Hartman | VP, People | 18 Gennaio 2019 A | — | 0 | 0 | $0 |
| Matthew Paul Kowalsky | VP, Legal and Secretary | 18 Gennaio 2019 A | 29.479 | 0 | 0 | $0 |
| Scott E. Toner | Senior VP of Commercial | 18 Gennaio 2019 A | 23.357 | 0 | 0 | $0 |
| Gottlieb Daniel Philip | VP Corporate Development | 18 Gennaio 2019 A | 244 | 0 | 0 | $0 |
| Michael Edward Solomon | Direttore | 15 Giugno 2026 A | 26.500 | 0 | 0 | $0 |
| Jane Huang | Direttore | 15 Giugno 2026 A | — | 0 | 0 | $0 |
| Barry P Flannelly | Direttore | 15 Giugno 2026 A | — | 0 | 0 | $0 |
| Cynthia Smith | Direttore | 15 Giugno 2026 A | — | 0 | 0 | $0 |
| Richard S Levy | Direttore | 15 Giugno 2026 A | 51.000 | 0 | 0 | $0 |
| Roger Garceau | Direttore | 15 Giugno 2026 A | 33.000 | 0 | 0 | $0 |
| Gregory Sargen | Direttore | 15 Giugno 2026 A | 31.000 | 0 | 0 | $0 |
| Luke M Beshar | Direttore | 15 Giugno 2026 A | 198.000 | 0 | 0 | $0 |
| Scott Braunstein | Direttore | 09 Giugno 2020 A | 26.500 | 0 | 0 | $0 |
| John Gordon Freund | Direttore | 08 Novembre 2019 C | 2.175.882 | 0 | 0 | $0 |
| Hubert Birner | Direttore | 08 Giugno 2018 A | 1.943.059 | 0 | 0 | $0 |
| Paul J Hastings | Direttore | 08 Giugno 2018 A | — | 0 | 0 | $0 |
| Scott A Canute | Direttore | 08 Giugno 2018 A | — | 0 | 0 | $0 |
| Garen G Bohlin | Direttore | 08 Giugno 2018 A | 53.312 | 0 | 0 | $0 |
| Jonathan S Leff | Direttore | 08 Giugno 2018 A | — | 0 | 0 | $0 |
| Brendan O'Leary | Direttore | 09 Giugno 2016 A | 1.387.198 | 0 | 0 | $0 |
| Dmitry Kobyzev | Direttore | 02 Giugno 2015 A | 1.165.344 | 0 | 0 | $0 |
| Gregory D Phelps | Direttore | 02 Giugno 2015 A | — | 0 | 0 | $0 |
| Opaleye, L.P. | Proprietario del 10% | 09 Gennaio 2020 A | 2.208.472 | 0 | 0 | $0 |
| Martin Sebastian Olivo | — | 10 Giugno 2021 P | 14.344 | 0 | 0 | $0 |
| Randall Marshall | — | 14 Settembre 2020 S | 585.600 | 0 | 0 | $0 |
| Timothy Haines | — | 12 Novembre 2019 C | 2.144.517 | 0 | 0 | $0 |
| Abingworth LLP | — | 12 Novembre 2019 C | 2.144.517 | 0 | 0 | $0 |
| Stuart A Kingsley | — | 08 Giugno 2018 A | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 8 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn | 08 Gennaio 2021 | — | Deposito iniziale | — | SEC |
| Opaleye Management Inc., Opaleye, L.P., James Silverman ×3 depositi | 25 Settembre 2020 | — | Deposito iniziale | — | SEC |
| Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn ×6 depositi | 17 Gennaio 2020 | — | Deposito iniziale | — | SEC |
| Abingworth LLP, Abingworth Bioventures VI, LP | 17 Gennaio 2020 | — | Deposito iniziale | M&A / vendita | SEC |
| Abingworth LLP 98-051-8585, Abingworth Bioventures VI, LP 98-040-3543 ×3 depositi | 14 Novembre 2019 | — | Deposito iniziale | Campagna per il consiglio di amministrazione | SEC |
| TVM Life Science Ventures VI L.P., TVM Life Science Ventures VI GmbH & Co. KG, TVM Life Science Ventures Management VI L.P., Hubert Birner, Stefan Fischer, Helmut Schuehsler ×2 depositi | 02 Agosto 2017 | — | Deposito iniziale | Investimento passivo | SEC |
| Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Mgmt III, L.P., Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield International Master Fund, L.P., Deerfield Private Design Fund III, L.P., James E. Flynn | 29 Giugno 2017 | — | Deposito iniziale | Investimento passivo | SEC |
| Skyline Venture Partners Qualified Purchaser Fund IV, L.P., Skyline Venture Management IV, LLC, John G. Freund, Yasunori Kaneko | 03 Novembre 2014 | — | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 22 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,16% | 55.748 NS | 31 Maggio 2026 | N-PORT |
| IWC · iShares Trust | 0,05% | 175.831 SH | 08 Agosto 2026 | Giornaliero |
| VFMO · VANGUARD WELLINGTON FUND | 0,03% | 141.979 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 91.844 NS | 31 Maggio 2026 | N-PORT |
| IWN · iShares Trust | 0,01% | 470.658 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 300.912 SH | 08 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 45.581 SH | 08 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,01% | 22.265 NS | 30 Aprile 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.336.607 SH | 08 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,01% | 179.929 NS | 30 Aprile 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2.419 NS | 31 Maggio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 3.715 NS | 30 Aprile 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1.891 NS | 31 Maggio 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1.912 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 48 NS | 31 Maggio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5.791 NS | 30 Aprile 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 18.477 NS | 30 Aprile 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 7.914 NS | 30 Aprile 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 20.174 NS | 30 Aprile 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 586.965 SH | 08 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.657.879 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.185 SH | 08 Agosto 2026 | Giornaliero |